R. Bahleda

Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase I trials

Cyrus Chargari, J. Soria, A. Levy, 2012, Investigational New Drugs.

Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials

O. Mir, A. Le Cesne, I. Ray-Coquard, 2022, ESMO open.

Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1-CREB1 fusion and ALK overexpression.

O. Mir, A. Le Cesne, A. Levy, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

ANTIBODY DRUG CONJUGATES IN OLDER PATIENTS: STATE OF THE ART.

S. Champiat, C. Smolenschi, S. Ponce Aix, 2023, Critical reviews in oncology/hematology.